From: Malignant acrospiroma: a case report in the era of next generation sequencing
Gene | Percentage of expected sequencing coverage* |
---|---|
AKT1, BRAF, CDKN2A, DDR2, EGFR, ERBB2, HRAS, JAK2, KDR, KRAS, MAP2K1, NRAS, NTRK1, NTRK2, PIK3R1, PTPRD, TP53 | 100% |
PIK3CA | 96.9% |
NOTCH1, NTRK3 | 96% |
ALK | 95% |
PTEN | 92.4% |
PIK3R2 | 78.8% |